Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.185 USD | -0.42% | +1.61% | -62.02% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.64M |
---|---|---|---|---|---|
Net income 2022 | -17M | Net income 2023 | -10M | EV / Sales 2022 | - |
Net cash position 2022 | 13.25M | Net cash position 2023 | 3.84M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.65
x | P/E ratio 2023 |
-1.53
x | Employees | 11 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.78% |
Latest transcript on Akari Therapeutics, Plc
1 day | -0.42% | ||
1 week | +1.61% | ||
Current month | -36.46% | ||
1 month | -37.14% | ||
3 months | -55.28% | ||
6 months | -67.08% | ||
Current year | -62.02% |
Managers | Title | Age | Since |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 22-03-27 |
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.185 | -0.42% | 10,002 |
24-04-25 | 1.19 | 0.00% | 3,902 |
24-04-24 | 1.19 | -1.65% | 7,532 |
24-04-23 | 1.21 | +2.54% | 4,872 |
24-04-22 | 1.18 | +1.18% | 13,919 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-62.02% | 9.43M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- AKTX Stock